Associated Papers
Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review.
Lombardi M et al.
Genes, 2023
38002982 (PubMed )
Supplement: genes-14-02039-s001.zip › genes-2688630-supplementary › genes-2688630.xlsx › 267_paz
Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD et al.
Acta Neuropathologica, 2015
Adenoviral expression of TDP-43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo.
Watabe K et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology, 2014
Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V et al.
Brain : a Journal of Neurology, 2011
The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR et al.
Current Opinion in Neurology, 2008
Update on recent molecular and genetic advances in frontotemporal lobar degeneration.
Bigio EH
Journal of Neuropathology and Experimental Neurology, 2008
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.
Kabashi E et al.
Nature Genetics, 2008
TDP-43 A315T mutation in familial motor neuron disease.
Gitcho MA et al.
Annals of Neurology, 2008
Select a paper to view details